Deadly drug rashes: Early recognition and multidisciplinary care

Area of Science:

• Dermatology
• Clinical Pharmacology

Background:

• Severe cutaneous adverse drug reactions (SCARs) pose significant diagnostic challenges.
• Key SCARs include Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), and drug-induced vasculitis.
• Distinguishing between these conditions is critical due to differing prognoses and management strategies.

Purpose of the Study:

• To outline the key differentiating features of potentially deadly drug rashes.
• To emphasize the diagnostic approach and initial management steps for SCARs.

Main Methods:

• Review of clinical features, timing of drug exposure, and systemic manifestations.
• Discussion of diagnostic aids including scoring systems and skin biopsy.
• Emphasis on prompt recognition and drug withdrawal.

Main Results:

• Differentiating SCARs involves assessing rash characteristics, timing relative to drug initiation, and presence of systemic involvement (e.g., mucosal lesions, organ dysfunction, eosinophilia).
• Skin biopsy remains the definitive diagnostic tool.
• Early identification and cessation of the offending drug are paramount.

Conclusions:

• Accurate differentiation of severe drug eruptions is essential for appropriate patient care.
• A systematic approach considering clinical presentation and diagnostic tools aids in diagnosis.
• Immediate withdrawal of the implicated medication is the cornerstone of management for SCARs.